ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,885Medicare Part D Prescriptions Filled, Including Refills

Rank: 371 out of 939

$349K Total Retail Price of All Prescriptions

Rank: 412 out of 939

206 Patients Receiving at Least One Drug in Part D
54%Patients 65 Years and Older
68% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Arkansas
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

28% of this provider’s 206 patients filled at least one prescription for a schedule three drug, compared to an average of 19%.

Risky Drugs to Seniors

2% of this provider’s 4,569 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$44 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

38 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Arkansas
HYDROCODONE-ACETAMINOPHEN 382 79 S3 1 1
HYDROCHLOROTHIAZIDE 291 189 2 12
LEVOTHYROXINE SODIUM 284 182 3 4
FUROSEMIDE 266 173 4 7
POTASSIUM CHLORIDE 256 185 5 9
CARISOPRODOL 223 22 R 6 51
METOPROLOL TARTRATE 215 140 7 10
METFORMIN HCL 199 133 8 8
METOPROLOL SUCCINATE 177 124 9 21
SIMVASTATIN 159 85 10 2
ATORVASTATIN CALCIUM 144 122 11 22
LISINOPRIL 142 63 12 3
DIOVAN 141 109 13 50
AMLODIPINE BESYLATE 129 97 14 6
BENAZEPRIL HCL 126 81 15 87
OMEPRAZOLE 125 81 16 5
CLOPIDOGREL 121 81 17 28
TRAMADOL HCL 106 70 18 16
DONEPEZIL HCL 106 101 18 30
ZOLPIDEM TARTRATE 102 62 20 20
NEXIUM 99 26 21 18
GLIMEPIRIDE 97 80 22 37
GABAPENTIN 94 56 23 11
MELOXICAM 87 75 24 14
ALENDRONATE SODIUM 80 78 25 40
AMITRIPTYLINE HCL 77 31 R 26 38
PRAVASTATIN SODIUM 75 63 27 13
QUINAPRIL HCL 72 57 28 133
CITALOPRAM HBR 72 30 28 15
PLAVIX 71 43 30 48
ATENOLOL 69 44 31 19
DIOVAN HCT 68 42 32 74
CYCLOBENZAPRINE HCL 66 19 R 33 36
PROMETHAZINE HCL 66 19 R 33 68
WARFARIN SODIUM 64 57 35 17
LISINOPRIL-HYDROCHLOROTHIAZIDE 64 41 35 23
SERTRALINE HCL 62 37 37 24
NAMENDA 59 58 38 49
LANTUS 58 55 39 59
ALLOPURINOL 56 43 40 31
KLOR-CON M20 56 53 40 90
TRAZODONE HCL 55 12 42 26
INSULIN SYRINGE 52 23 43 97
BUSPIRONE HCL 51 30 44 123
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 21, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.